47
Track 4: Health IT Innovators and Game Changers What’s FDA Approval and HIPAA Got To Do With It? Matthew Fisher, Esq. Co-Chair Health Law Group Mirick O’Connell Worcester, MA

What’s FDA Approval and HIPAA Got To Do With It?€™s FA Approval and HIPAA Got To Do With It ... • Have to monitor activities to find non-compliance or other ... • What are

Embed Size (px)

Citation preview

Track 4: Health IT Innovators and Game Changers

What’s FDA Approval and HIPAA Got To Do With It?

Matthew Fisher, Esq.

Co-Chair Health Law Group

Mirick O’Connell

Worcester, MA

Track 4: Health IT Innovators and Game Changers

What is HIPAA?

• The Health Insurance Portability and Accountability Act (“HIPAA”) of 1996

• Addresses numerous healthcare issues • Was signed into law by President Clinton on August

21, 1996

• Privacy and Security Rules under HIPAA are designed to protect sensitive information known as “Protected Health Information” (“PHI”)

• The Health Information Technology for Economic and Clinical Health Act of 2009 expanded HIPAA’s coverage to include electronic information and require notification of breaches

• Also covers other issues such as billing and insurance provisions, but those will not be covered here

Track 4: Health IT Innovators and Game Changers

HIPAA: Who is Subject?

• Covered Entities• Health Care Providers (meeting certain conditions)

• Health Insurers

• Health Care Clearinghouses

• Business Associates• Any entity that assists with or performs functions for or on behalf of a

covered entity for any activity regulated by HIPAA

• Very broad

• Subcontractors of Business Associates

Track 4: Health IT Innovators and Game Changers

HIPAA: Privacy Rule

General Purpose – regulates “use” and “disclosure” of PHI by “covered entities,” “business associates,” and subcontractors

o Allows for certain, limited uses and disclosures without requiring authorization

o Others require notice to and/or authorization from the patient

Imposes numerous compliance requirements on entities (e.g. tracking, reporting, training)

Track 4: Health IT Innovators and Game Changers

HIPAA: Security Rule

• General purpose – creates standard security measures for the protection of PHI that is created, received, used or maintained by covered entity

• Includes various technical, administrative, and physical requirements and specifications

• A primary concern with increasing number of threats to medical and electronic information

Track 4: Health IT Innovators and Game Changers

HIPAA: Breach Notification Rule

General purpose - requires notification if a “breach” of PHI occurs

o Applies to a breach by any entity handling PHI

o Final rule claimed to create an objective standard, but still has subjective elements

o Breach presumed to have occurred

o Breached entity must prove why notification is not needed

Image from www.buzzingfeed.com

Track 4: Health IT Innovators and Game Changers

Why Care About HIPAA?• How do HIPAA and medical devices companies interact?

• Depends on what medical device does, who will use it, where PHI may go, what PHI will be stored, and more

• Typically, medical device company be a business associate

• Device collects PHI• Stores and/or transmits somewhere – to data storage,

health information exchange, provider, or others

• Means medical device company viewed as acting for or on behalf of a covered entity

• BUT, can be health care provider (or covered entity) too• Does medical device company bill for, furnish, or provide

“health care?”

• Compliance gains trust of clients• Compliance expected

• Sets baseline for standards in operations

Image from www.hipaajournal.com

Track 4: Health IT Innovators and Game Changers

How Comply with HIPAA

• How can a medical device company comply with HIPAA?• First Step – review terms of business associate agreement

• Second Step – perform risk analysis

• Third Step – prepare policies and procedures

• Fourth Step – implement policies and procedures

• Fifth Step – continually monitor and refine policies and procedures

Image from www.linkgard.com

Track 4: Health IT Innovators and Game Changers

HIPAA Compliance – First Step

• Business Associate Agreement• Terms driven by HIPAA regulations

• Requirements found in both the Privacy Rule and the Security Rule

• Generally, business associates need to comply with all of the Security Rule and select pieces of the Privacy Rule

• What else?

• Look at terms to understand what is stated

• Can impose faster response times than may get directly under HIPAA regulations

• See if there are requirements above and beyond the HIPAA regulations

Track 4: Health IT Innovators and Game Changers

HIPAA Compliance – Second Step

• Perform a RISK ANALYSIS

• Essential element and first step in complying with the Security Rule

• Means to “conduct an accurate and thorough assessment of the potential risks and vulnerabilities to the confidentiality, integrity, and availability of electronic protected health information.” (45 CFR 164.308(a)(1)(ii)(A))

• Comprehensive overview that enables entity to assess what needs to be done

Image from www.foxgrp.com

Track 4: Health IT Innovators and Game Changers

HIPAA Compliance – Third Step

• For Security Rule• Use results from risk analysis

• Go through technical, administrative, and physical components

• Implement all required and analyze addressable elements

• For Privacy Rule• If only in a BA capacity, then Business Associate Agreement provides a

guide

• Will not need to implement all aspects of Privacy Rule

• Do not utilize off the shelf policies and procedures

• Seek assistance in developing and/or reviewing

Track 4: Health IT Innovators and Game Changers

HIPAA Compliance – Fourth Step

• Now that you have policies and procedures, have to implement

• Means educating, training, and generally getting people aware

• If no one in the organization understands what is required, cannot expect compliance

• Education includes explaining what HIPAA is and does

• Training should occur with implementation (or new hire) and then recur annually

Image from www.hipaasecurenow.com

Track 4: Health IT Innovators and Game Changers

HIPAA Compliance – Fifth Step

• Monitor, modify, listen, and evolve

• Compliance is not static, must continually adapt

• Have to monitor activities to find non-compliance or other issues

• Modify when new issues come up

• Listen to employees or others interacting with the policies and procedures

• Make HIPAA compliance a living, breathing plan• Everyone needs to buy in and play a role

Track 4: Health IT Innovators and Game Changers

Is Medical Device Company Always a BA?

• Do not forget: possible for medical device company to be a health care provider

• Means not necessarily in business associate category

• How does it happen?• If provides health care as defined by HIPAA, then will be a health care

provider• Can occur if counsel physician on how to use the device, or assist in

adjusting or using the device, among other ways• If the device company will bill directly, can receive PHI

• What are implications of being a health care provider?• May not need a Business Associate Agreement• Protected Health Information can be shared in different ways

• Some potential to also be a covered entity• If a covered entity, then need to comply with all aspects of the Privacy

Rule

Track 4: Health IT Innovators and Game Changers

What Does HIPAA Mean for the Actual Device?

• How is a medical device made compliant?• Remember, entities are compliant, not devices

• By following steps identified above, entity can be compliant

• Having device meet security standards and have appropriate security controls helps the entity comply

• Pay most attention to security requirements• What standards use? – NIST, FDA, more

• Consider where PHI going

• Physician, HIE, other

• Gaining attention from hacking reports

Image from www.hitechanswers.net

Track 4: Health IT Innovators and Game Changers

Summary

• Never forget, entities are compliant, not devices

• Determine role being played, i.e. business associate, health care provider, or maybe covered entity

• No matter what, develop policies and procedures

• Put significant focus on Security Rule

Image from www.contactcenterworld.com

Track 4: Health IT Innovators and Game Changers

Contact Information

Matthew Fisher, Esq.• Email: [email protected]

• Phone: 508-929-1648

• Twitter: matt_r_fisher

• LinkedIn: https://www.linkedin.com/in/matthewreidfisher

Image from www.sscss.ca

Track 4: Health IT Innovators and Game Changers

VITL Summit 2015 Health IT Innovators and

Game Changers

FDA 101 and Digital Health

Linda Ricci

Office of Device Evaluation

Digital Health Policy

19

Track 4: Health IT Innovators and Game Changers

Outline

What is CDRH?

How does the FDA think about Digital Health?

What does that mean to manufacturers?

20

Track 4: Health IT Innovators and Game Changers 21

Food and Drug Administration

FDA Commissioner

Center for Food Safety & Applied

Nutrition (CFSAN)

Center for Drug Evaluation & Research

(CDER)

Center for Biologics Evaluation &

Research (CBER)

Center for Devices & Radiological

Health (CDRH)

Center for Veterinary Medicine (CVM) Office of Regulatory Affairs (ORA)

Office of Combination Products Center for Tobacco Products

Track 4: Health IT Innovators and Game Changers22

Center for Devices and Radiological Health (CDRH)

Responsible for regulating firms who manufacture, repackage, relabel, and/or import medical devices and in-vitro diagnostics for sale in the United States.

Regulates radiation-emitting electronic products (medical and non-medical) such as lasers, x-ray systems, ultrasound equipment, microwave ovens and color televisions

Track 4: Health IT Innovators and Game Changers

The products we regulate…

23

Track 4: Health IT Innovators and Game Changers24

Risk based Oversight

Class I•General Controls

Class II• General controls

• Special controls

Class III• General controls

• Premarket approval (PMA)

Increasing RiskClassification determines extent of regulatory control (Risk Based)

General Controls•Electronic Establishment Registration

•Electronic Device Listing

•Adulteration / Misbranding

•Premarket Notification [510(k)] (unless exempt)

•Quality Systems

•Labeling

•Medical Device Reporting (MDR)

Special Controls (addressing Risk)•Guidelines (e.g., Glove Manual)

•Mandatory Performance Standard

•Recommendations or Other Actions

•Special Labeling (e.g., 882.5970, Cranial

Orthosis)

Track 4: Health IT Innovators and Game Changers

Revolution in Digital Health

25

Track 4: Health IT Innovators and Game Changers

Health IT Socio Technical System

From: Institute of Medicine. 2012. Health IT and Patient Safety: Building Safer Systems for Better Care. Washington, DC: The National Academies Press.

26

Track 4: Health IT Innovators and Game Changers

500 millionSmartphone users will be using health apps by 20151

1 Research2Guidance 2010

“By the end of 2017, the total mHealth market revenue will have grown by 61% (CAGR) to reach US$26 billion.” 2

2 research2guidance report 2013-2017

27

Track 4: Health IT Innovators and Game Changers

FDA Digital Health Approach

Risk Based

Narrowly Tailored Approach

Functionality Based

Platform Independent

Promote Innovation

Patient-Centric

28

Track 4: Health IT Innovators and Game Changers

Practical Digital Health

o Is my product actively regulated by the FDA?

o How is my digital health device regulated?

o What data do I need to provide?

29

Track 4: Health IT Innovators and Game Changers

Medical Device Definition

A medical device is a product that is intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease that does not achieve its principal intended purposes by chemical action or by being metabolized*.

As simple as a tongue depressor

or a thermometer

As complex as robotic surgery devices

©2006 Intuitive Surgical, Inc.

* Section 201(h) of the Food, Drugs and Cosmetics Act

30

Track 4: Health IT Innovators and Game Changers

Functionality focused

31

Track 4: Health IT Innovators and Game Changers

Mobile Medical Apps

• Guidance issued Feb 9, 2015

• Focuses only on traditionally regulated functionality

o Cleared, approved or otherwise regulated

• Identifies types of apps that FDA does not intend to enforce regulatory requirements

• Clarifies what is not a device –(Outside of FDA’s Jurisdiction)

Mobile apps not

considered

“medical devices”

MMA

Lower risk

mobile apps that

meet “device” definition

but not considered “MMA”

Mobile Medical

Apps

32

Track 4: Health IT Innovators and Game Changers

Mobile medical apps (MMA)

No regulatory requirements

• Patient self-management apps• Tools to organize and track health information

(not for treating or adjusting medications)• Tools to access to health information document

and communicate with health care providers• Tools that automate simple health care

providers tasks

Enforcement Discretion

Mobile apps not

considered

“medical devices”

MMA

Lower risk

mobile apps that

meet “device” definition

but not considered “MMA”

Mobile apps that meet “device” definition that • are used as an accessory to

already regulated medical device, or

• transforms a mobile communication device into a regulated medical device.

focus of oversight

33

Track 4: Health IT Innovators and Game Changers

Digital Health – Mobile Apps

34

Track 4: Health IT Innovators and Game Changers

How is my device actively regulated (and what does that mean)?

Risk-based approacho What are the risks to the patient that can be attributed to the device

Similarity to other deviceso Are there devices that use similar technology?

o Are there devices that have similar claims?

Recent policy decisions

35

Track 4: Health IT Innovators and Game Changers

Determining Classification and Regulatory Requirements

Device Regulationso 21 CFR parts 800-898

FDA Web site includingo Product Classification Database

o 510(k) Clearance Database

o Device Guidance Documents

513(g)o Written request for agency’s views about the classification and

regulatory requirements that may be applicable to your device

o http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm209841.htm

36

Track 4: Health IT Innovators and Game Changers

If Class I….

Lowest level of risk

Most often no need for premarket application

37

Track 4: Health IT Innovators and Game Changers

If Class II…

Likely will need a 510(k) or a de novo

Compare to similar device (510k)

If no predicate available (de novo)

38

Track 4: Health IT Innovators and Game Changers

If Class III….

PMA is needed

Reserved for devices that present the highest level of risk

39

Track 4: Health IT Innovators and Game Changers

What do I need to provide?

If a premarket submission is necessary, adequate information on the device and the performance should be included

Specific requirements are dependent on device and classification

40

Track 4: Health IT Innovators and Game Changers

Pre-Submission

A formal written request from an applicant for feedback from FDA

Request include specific questions regarding review issues relevant to a planned IDE or marketing application (e.g., questions regarding pre-clinical and clinical testing protocols or data requirements).

41

Track 4: Health IT Innovators and Game Changers

Resources

Mobile Medical Apps Website o Google “FDA mobile apps”

Email Inbox specifically for questionso [email protected]

o [email protected]

Traditional Resourceso Defined regulations

o 513(g)

o Pre-submission

42

Track 4: Health IT Innovators and Game Changers

Summary

Digital Health is changing how health care is delivered

FDA is committed to establishing policies for digital health that promote innovation while maintaining patient safety

FDA has resources available to help determine if and how a digital health product is regulated

43

Track 4: Health IT Innovators and Game Changers

Questions?

44

Track 4: Health IT Innovators and Game Changers

What is a Predicate?

21 CFR Part 807.92(a)(3)*

An identification of the legally marketed device to which the submitter claims equivalence. A legally marketed device to which a new device may be compared for a determination regarding substantial equivalence is a device that was legally marketed prior to May 28, 1976, or a device which has been reclassified from class III to class II or I (the predicate), or a device which has been found to be substantially equivalent through the 510(k) premarket notification process.

*Regulation written in 1990.

45

Track 4: Health IT Innovators and Game Changers

What is Substantial Equivalence?

1976 Congressional Record

“The term ‘substantially equivalent’ is not intended to be so narrow as to refer only to devices that are identical to marketed devices nor so broad as to refer to devices which are intended to be used for the same purposes as marketed products. The committee believes that the term should be construed narrowly where necessary to assure the safety and effectiveness of a device but not narrowly where differences between a new device and a marketed device do not relate to safety and effectiveness.”

46

Track 4: Health IT Innovators and Game Changers 47

• Format for Traditional and Abbreviated 510(k)s• The New 510(k) Paradigm- Alternate

Approaches to Demonstrating Equivalence• Deciding When to Submit a 510(k) for a

Change to an Existing Device

Guidance for Industry and Staff